Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

  • 📰 NBCNewYork
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Brain implant company Paradromics is preparing for human trials, while President Biden’s poor debate performance affected health-care stocks.

The brain implant startup Paradromics is taking steps to prepare for its first in-human trial next year, and the company announced on Monday that it has launched its official

Paradromics' system will initially serve as an assistive communication device that can turn brain signals into outputs like text or synthesized speech. This means patients with severe paralysis could eventually use it to regain their ability to communicate.BCIs have been studied in academia for decades, and several other companies, including Elon Musk's Neuralink, have been developing their own systems.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 270. in ERROR

Finance Finance Latest News, Finance Finance Headlines